Having trouble viewing this email? Click here.

December 2021    


Merck Announces Additional $150M Commitment Through 2025 to Help End Maternal Mortality Inequities


Merck announced an additional $150M commitment through Merck for Mothers to further advance the initiative's mission of helping create a world where no woman has to die giving life. The investment aims to support programs that deliver essential health services to reach 25 million women by 2025.


Explore How Private Sector Engagement Can Help Close the Gap in Improving RMNCAH


In the third and final report from Devex in the Maternity Matters: Funding the Future series, Devex delves deeper into the learnings from private sector engagement for RMNCAH as well as donor profiles for The World Bank, European Commission, UK Foreign, Commonwealth and Development Office and SIDA/Swedfund.


Podcast: In Conversation on Progress, Potential and Possibilities


Temitayo Erogbogbo, Director of Advocacy for Merck for Mothers joined Ira Pastor of the Progress, Potential and Possibilities Podcast to discuss the initiative, the company's broader social impact portfolio, maternal mortality amid COVID-19, technology platforms for UHC and more.

If you no longer wish to receive updates from Merck for Mothers please click here to opt out.

At Merck, our global privacy program is based on building and preserving the trust of our stakeholders in how we protect personal information about them. Please read more about our privacy commitment. For more information, please read our Global Data Practices Notice for Healthcare Professionals.

If you have questions relating to Merck prescription products, your medical condition or personal health matters, please contact your physician or healthcare provider since he or she is most familiar with your medical condition. Merck cannot respond to questions about general medical information or information regarding your specific condition. To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 800-444-2080.

To ensure delivery of this e-newsletter, add newsletter@merckformothers.com to your address book.

This email was sent by: Merck for Mothers, Merck & Co., Inc., Rahway, NJ, USA